Vibunazole and its enantiomers. Synthesis, antifungal activity, and pharmacokinetics.
Ritter
W
W
Pharmaceutical Research Center, Bayer AG, Wuppertal, Federal Republic of Germany.
Holmwood
G
G
Ahr
H J
HJ
Detzer
K
K
Kraatz
U
U
Plempel
M
M
Scherling
D
D
Siefert
H M
HM
D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology*; D002176:Candida albicans / Q000187:drug effects; D007536:Isomerism; D008826:Microbial Sensitivity Tests; D015394:Molecular Structure; D013329:Structure-Activity Relationship; D014230:Triazoles / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000633:toxicity
D000935:Antifungal Agents; D014230:Triazoles; C037494:vibunazole